Best imaging modality for neuroendocrinal tumors –

Because of its greater sensitivity than conventional imaging (CT, MRI, USG) and its ability to localize tumor throughout the body at one time, SRS (Somatostatin receptor scintigraphy) is now the imaging modality of choice for localizing both primary and metastatic NET tumors. (except for insulinoma). Best modality of localizing insulinoma is endoscopic USG.